These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16899405)

  • 21. [Undecatungstophosphate sensitized strains of methicillin-resistant Staphylococcus aureus to beta-lactams].
    Tajima Y
    Rinsho Byori; 2002 Feb; 50(2):173-85. PubMed ID: 11925856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ILSMRs (intensifier of beta-lactam-susceptibility in methicillin-resistant Staphylococcus aureus) from Tara [Caesalpinia spinosa (Molina) Kuntze].
    Kondo K; Takaishi Y; Shibata H; Higuti T
    Phytomedicine; 2006 Feb; 13(3):209-12. PubMed ID: 16428032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-Thiolated beta-lactam antibacterials: effects of the N-organothio substituent on anti-MRSA activity.
    Heldreth B; Long TE; Jang S; Reddy GS; Turos E; Dickey S; Lim DV
    Bioorg Med Chem; 2006 Jun; 14(11):3775-84. PubMed ID: 16480881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7beta-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3'.
    Yoshizawa H; Kubota T; Itani H; Minami K; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4221-31. PubMed ID: 15246098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus.
    Scheinfeld N
    J Drugs Dermatol; 2007 Jan; 6(1):97-103. PubMed ID: 17373167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities.
    Fukumoto A; Kim YP; Hanaki H; Shiomi K; Tomoda H; Omura S
    J Antibiot (Tokyo); 2008 Jan; 61(1):7-10. PubMed ID: 18305353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-thiolated 2-oxazolidinones: a new family of antibacterial agents for methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
    Mishra RK; Revell KD; Coates CM; Turos E; Dickey S; Lim DV
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2081-3. PubMed ID: 16464583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solid-phase synthesis and antibacterial activity of hydroxycinnamic acid amides and analogues against methicillin-resistant Staphylococcus aureus and vancomycin-resistant S. aureus.
    Yingyongnarongkul BE; Apiratikul N; Aroonrerk N; Suksamrarn A
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5870-3. PubMed ID: 16942872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ceftobiprole: a new beta-lactam antibiotic.
    Stein RA; Goetz RM; Ganea GM
    Int J Clin Pract; 2009 Jun; 63(6):930-43. PubMed ID: 19490203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New treatments for methicillin-resistant Staphylococcus aureus.
    Stryjewski ME; Corey GR
    Curr Opin Crit Care; 2009 Oct; 15(5):403-12. PubMed ID: 19561492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G; Moellering RC
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of antibiotics combined with natural polyphenols against clinical methicillin-resistant Staphylococcus aureus (MRSA).
    Lin RD; Chin YP; Hou WC; Lee MH
    Planta Med; 2008 Jun; 74(8):840-6. PubMed ID: 18546080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propenylamide and propenylsulfonamide cephalosporins as a novel class of anti-MRSA beta-lactams.
    Pohlmann J; Vasilevich NI; Glushkov AI; Kellenberger L; Shapiro S; Caspers P; Page MG; Danel F
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4635-8. PubMed ID: 20576430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-Methylthio beta-lactam antibacterials: effects of the C3/C4 ring substituents on anti-MRSA activity.
    Turos E; Coates C; Shim JY; Wang Y; Leslie JM; Long TE; Reddy GS; Ortiz A; Culbreath M; Dickey S; Lim DV; Alonso E; Gonzalez J
    Bioorg Med Chem; 2005 Dec; 13(23):6289-308. PubMed ID: 16185880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
    Garrison MW; Nuemiller JJ
    Int J Antimicrob Agents; 2007 Feb; 29(2):191-6. PubMed ID: 17174074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates.
    Kotlus BS; Wymbs RA; Vellozzi EM; Udell IJ
    Am J Ophthalmol; 2006 Nov; 142(5):726-9. PubMed ID: 17056356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multivalent approach to drug discovery for novel antibiotics.
    Long DD; Aggen JB; Christensen BG; Judice JK; Hegde SS; Kaniga K; Krause KM; Linsell MS; Moran EJ; Pace JL
    J Antibiot (Tokyo); 2008 Oct; 61(10):595-602. PubMed ID: 19168973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of ceftobiprole, daptomycin, linezolid, and vancomycin against methicillin-resistant staphylococci associated with endocarditis and bone and joint infection.
    Rouse MS; Steckelberg JM; Patel R
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):363-5. PubMed ID: 17449212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.